Form 4: Guardant Health CMO Craig Eagle Reports Routine RSU Vesting and Tax Withholding

Guardant Health's Chief Medical Officer, Craig Eagle, reported the vesting of restricted stock units and associated tax withholding transactions on July 1, 2025, as detailed in a recent SEC Form 4 filing.

Summary

• Craig Eagle, Chief Medical Officer of Guardant Health, Inc., reported transactions on July 1, 2025, involving the vesting of Restricted Stock Units (RSUs) and the subsequent disposition of shares to cover tax withholding obligations.
• A total of 1,714 common shares were acquired through the vesting of an RSU award granted on November 7, 2022, and another 1,667 common shares were acquired from an RSU award granted on December 13, 2023.
• Concurrently, 1,714 common shares were disposed of at a price of $50.71 per share to satisfy tax withholding obligations related to the RSU vesting.
• Following these transactions, Craig Eagle's direct beneficial ownership of common stock is 36,791 shares.
• His direct beneficial ownership of Restricted Stock Units is 8,571 units from the November 7, 2022 award and 8,337 units from the December 13, 2023 award.

Sentiment

Score: 5

Explanation: The filing details routine vesting of restricted stock units and associated tax withholding, which are standard compensation events and do not indicate a significant positive or negative shift in company fundamentals or insider sentiment.

Positives

• The vesting of Restricted Stock Units indicates the fulfillment of compensation agreements, aligning executive incentives with company performance.
• The transactions are routine and expected as part of executive compensation plans.

Future Outlook

This document reports past and current transactions and does not provide forward-looking statements or guidance.

Industry Context

This filing is a routine insider transaction report and does not provide broader industry context or trends.

Stakeholder Impact

• Shareholders: Minor, as it's a routine compensation event reflecting the ongoing compensation structure for a key executive.

Next Steps

• The remaining 75% of the November 7, 2022 RSU award is scheduled to vest in equal quarterly installments over the remaining three-year period after October 1, 2023.
• The remaining 67% of the December 13, 2023 RSU award is scheduled to vest in equal quarterly installments over the remaining two-year period after October 1, 2024.

Key Dates

Keywords

Guardant Health, GH, Craig Eagle, Chief Medical Officer, CMO, SEC Form 4, insider transaction, restricted stock units, RSU vesting, tax withholding, beneficial ownership, executive compensation